
BAVENCIO® (avelumab) For Healthcare Professionals
Discover BAVENCIO® (avelumab) for the treatment of metastatic Merkel cell carcinoma & first-line maintenance treatment for metastatic urothelial carcinoma.
BAVENCIO® Patient
BAVENCIO is a prescription medicine used to treat: a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread
About BAVENCIO® (avelumab) – For metastatic Merkel cell …
BAVENCIO is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread.
Locally Advanced or Metastatic UC | BAVENCIO® (avelumab) For …
Learn about BAVENCIO® (avelumab) as the first and only immunotherapy approved for the first-line maintenance treatment of metastatic urothelial carcinoma. Learn more
PDF-1.4 %âãÏÓ 297 0 obj > endobj xref 297 221 0000000016 00000 n 0000005524 00000 n 0000005732 00000 n 0000005803 00000 n 0000005845 00000 n 0000006051 00000 n 0000006606 00000 n 0000006733 00000 n 0000006876 00000 n 0000007019 00000 n 0000007161 00000 n 0000007303 00000 n 0000007446 00000 n 0000007588 00000 n ...
Mechanism of Action | BAVENCIO® (avelumab) For HCPs
Find the BAVENCIO® (avelumab) mechanism of action. Explore how BAVENCIO® a PD-L1 inhibitor activates dual immune function. Learn more
BAVENCIO is the first medicine that the Food and Drug Administration (FDA) approved to treat metastatic MCC in adults and children ages 12 and older. BAVENCIO is a man-made antibody. Your body naturally produces antibodies to help your immune system work. BAVENCIO is delivered by an intravenous (IV) infusion directly into your bloodstream.
Metastatic Merkel Cell Carcinoma | BAVENCIO® (avelumab)
BAVENCIO is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread. It is not known if BAVENCIO is safe and effective in children under the age of 12.
Taking Bavencio
BAVENCIO ® (avelumab) is a medicine that may treat certain cancers by working with your immune system. BAVENCIO can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death.
Dosing & Administration | BAVENCIO® (avelumab) For HCPs
Explore dosing options for BAVENCIO® (avelumab) a treatment for locally advanced or metastatic Urothelial Carcinoma and metastatic Merkel cell carcinoma. Learn more